Who we are
BioCurate’s mission is to grow the Victorian and Australian biotech sector by translating medical research outputs into high quality preclinical candidates for the bio-pharmaceutical industry. A bold, collaborative venture, BioCurate was jointly formed by the University of Melbourne and Monash University, with support from the Victorian State Government. BioCurate is dedicated to identifying promising biomedical research discoveries and managing their translation into high quality pre-clinical candidates. BioCurate’s team of experts bring hands-on industry experience and a global track-record, providing a robust bridge between academia and industry within the biotechnology sector to accelerate the development of new therapies. We can help you change the future.
We bridge the gap
Our collaborative team of global biomedical experts bridge the gap between:
Academia + Industry
Ideas + Impact
Focus + Collaboration
Collaboration + Commercialisation
Research + Translation
The BioCurate team
Our team
170
More than 170 years of combined biotech/pharma industry experience
13
Directly involved in over 13 Investigational New Drug applications (INDs)
30
Responsible for 30 therapeutics currently in the clinic
$2.4B
Directly involved in deals worth a cumulative total of more than $2.4 billion
Twitter feed
And the exciting part 😍
Oral presentation winners:
@KhabibHamizan #1 student oral p
@ChloeLi595 #2 student oral p
@BhavanaNayer #1 postdoc oral p
Kristy Swiderski #2 postdoc oral p
@DaleFTaylor people's choice
Final program for the #I2T2024 symposium includes: 🌟 Invited speakers from across the Melbourne biotech sector
🏆 Updates from past MTx pitch competition winners
🎙️Expert panel on research commercialisation – sponsored by @BioCurate
🌟 A huge thank you to everyone who joined us at @AusBiotech 2024!
We celebrated collaboration and innovation—key to @BioCurate's mission of translating exceptional research into impactful therapies. Key highlights include engaging discussions and networking with industry…
Just wrapped up an insightful panel on 'Considerations when investing in early-stage university spin-outs' at #AusBio2024! 🎉
Dr Kathy Nielsen @BioCurate, shared expertise alongside representatives from Brandon Capital, @MonashUni, @UniseedFund and SYNthesis BioVentures.
Exciting…
🚨 Attention #AusBio2024 attendees! 🚨
Don't miss out on the "Considerations when investing in early-stage university spin-outs" panel today at 2:20 PM - 3:05 PM! 🕑
Our very own Dr Kathy Nielsen, CEO at BioCurate, will be sharing her expertise alongside:
Dr Michael Bettess…
#AusBio2024 is well underway! Don’t forget to visit BioCurate at the @VicGovAu Pavilion booth #4.
We look forward to forming new connections with the sector. Stay tuned as we’ll be tweeting throughout the conference.
@AusBiotech